180 related articles for article (PubMed ID: 12384433)
1. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
Shaker S; Bernstein M; Momparler LF; Momparler RL
Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
[TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors.
Jóna A; Khaskhely N; Buglio D; Shafer JA; Derenzini E; Bollard CM; Medeiros LJ; Illés A; Ji Y; Younes A
Exp Hematol; 2011 Oct; 39(10):1007-1017.e1. PubMed ID: 21767511
[TBL] [Abstract][Full Text] [Related]
4. Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission.
Stanović S; Boranić M; Petrovecki M; Batinić D; Skodlar J; Nemet D; Labar B
Haematologia (Budap); 2000; 30(1):1-10. PubMed ID: 10841318
[TBL] [Abstract][Full Text] [Related]
5. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
6. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein.
Aron JL; Parthun MR; Marcucci G; Kitada S; Mone AP; Davis ME; Shen T; Murphy T; Wickham J; Kanakry C; Lucas DM; Reed JC; Grever MR; Byrd JC
Blood; 2003 Jul; 102(2):652-8. PubMed ID: 12649137
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
8. The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
Rosato RR; Almenara JA; Cartee L; Betts V; Chellappan SP; Grant S
Mol Cancer Ther; 2002 Feb; 1(4):253-66. PubMed ID: 12467221
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells.
Murata M; Towatari M; Kosugi H; Tanimoto M; Ueda R; Saito H; Naoe T
Jpn J Cancer Res; 2000 Nov; 91(11):1154-60. PubMed ID: 11092981
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines.
Ishitsuka K; Hanada S; Uozumi K; Utsunomiya A; Arima T
Leuk Lymphoma; 2000 May; 37(5-6):649-55. PubMed ID: 11042529
[TBL] [Abstract][Full Text] [Related]
11. Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells.
Nimmanapalli R; Fuino L; Stobaugh C; Richon V; Bhalla K
Blood; 2003 Apr; 101(8):3236-9. PubMed ID: 12446442
[TBL] [Abstract][Full Text] [Related]
12. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
Yu J; Batova A; Shao L; Carrera CJ; Yu AL
Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.
Zada AA; Singh SM; Reddy VA; Elsässer A; Meisel A; Haferlach T; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Apr; 22(15):2296-308. PubMed ID: 12700665
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
Mahlknecht U; Schönbein C
Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
[TBL] [Abstract][Full Text] [Related]
15. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
[TBL] [Abstract][Full Text] [Related]
16. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
Niitsu N; Higashihara M; Honma Y
Exp Hematol; 2002 Nov; 30(11):1273-82. PubMed ID: 12423680
[TBL] [Abstract][Full Text] [Related]
17. Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo.
Sasakawa Y; Naoe Y; Inoue T; Sasakawa T; Matsuo M; Manda T; Mutoh S
Cancer Lett; 2003 Jun; 195(2):161-8. PubMed ID: 12767524
[TBL] [Abstract][Full Text] [Related]
18. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.
Kamitani H; Taniura S; Watanabe K; Sakamoto M; Watanabe T; Eling T
Neuro Oncol; 2002 Apr; 4(2):95-101. PubMed ID: 11916500
[TBL] [Abstract][Full Text] [Related]
19. Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
Rots MG; Pieters R; Kaspers GJ; van Zantwijk CH; Noordhuis P; Mauritz R; Veerman AJ; Jansen G; Peters GJ
Blood; 1999 Feb; 93(3):1067-74. PubMed ID: 9920857
[TBL] [Abstract][Full Text] [Related]
20. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
Spiekermann K; Faber F; Voswinckel R; Hiddemann W
Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
